Andere talen Exact Sciences Corporation

Aandelen

EXAS

US30063P1057

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
49,84 ^USD	-7,84%		-1,07%	-32,63%

24/05	Sectorupdate: Gezondheidszorgaandelen gaan vrijdag voor de beurs vooruit	MT
24/05	Exact Sciences presenteert nieuwe gegevens op Oncology Annual Meeting die prognostische waarde van borstkankertest bevestigen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ASCO®: Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von Behandlungsergebnissen	25/05
Sector Update: Health Care Stocks Advance Pre-Bell Friday	24/05
Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test	24/05
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®	24/05
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations At Asco®	24/05
U.S. FDA advisers back approval for Guardant's cancer test	23/05
Exact Sciences Earns 2024 Great Place to Work Certification	23/05
Exact Sciences Earns 2024 Great Place To Work® Certification™	22/05
Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed	21/05
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy	21/05
Exact Sciences : TCFD Report for the FY ended 12/29/2021	20/05
Foundation Fighting Blindness Partners with PreventionGenetics and InformedDNA to Advance My Retina Tracker Genetic Testing Program	16/05
Exact Sciences : Names Aaron Bloomer as New Chief Financial Officer	14/05
USA-Les valeurs à suivre à Wall Street (actualisé)	09/05
Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours	08/05
Exact Sciences: Q1 Earnings Snapshot	08/05
Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M	08/05
Exact Sciences Announces First-Quarter 2024 Results	08/05
Exact Sciences Corporation Maintains Revenue Guidance for the Full Year of 2024	08/05
Exact Sciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Exact Sciences Corporation

Aandelen

EXAS

US30063P1057

Andere talen

Filters